Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Comprehensive Loss

v3.24.2.u1
Condensed Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Condensed Statements of Comprehensive Loss [Abstract]        
License and collaborations revenue $ 1,112 $ 3,674 $ 2,823 $ 5,423
Operating expenses:        
General and administrative 3,354 4,340 8,024 6,625
Research and development 6,086 4,723 10,835 10,318
Total operating expenses 9,440 9,063 18,859 16,943
Loss from operations (8,328) (5,389) (16,036) (11,520)
Other income, net 563 428 1,165 768
Loss before income taxes (7,765) (4,961) (14,871) (10,752)
Benefit (provision) for income taxes 0 0 0 0
Net loss (7,765) (4,961) (14,871) (10,752)
Other comprehensive loss, net of tax 0 0 0 0
Comprehensive loss $ (7,765) $ (4,961) $ (14,871) $ (10,752)
Net loss per share:        
Basic (in dollars per share) $ (0.3) $ (0.24) $ (0.59) $ (0.51)
Diluted (in dollars per share) $ (0.3) $ (0.24) $ (0.59) $ (0.51)
Number of shares used in per share calculations:        
Basic (in shares) 25,827,265 20,959,807 25,175,596 20,949,763
Diluted (in shares) 25,827,265 20,959,807 25,175,596 20,949,763